NEW YORK – With flu season approaching, Finland's Abacus Diagnostica has decided to roll out a multiplex RT-PCR test for SARS-CoV-2, influenza A and B, and respiratory syncytial virus. The assay should have a CE-IVD mark by November and will serve the molecular diagnostics firm's growing European client base, according to CEO Erno Sundberg.
"This is a good fit for labs that are worried about running out of testing capacity when flu season hits," he said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
